Treatment Preference Study of Patients with Non-Muscle Invasive Bladder Cancer in Japan

Treatment Preferences of Patients with Non-Muscle Invasive Bladder Cancer in Japan: A Discrete Choice Experiment - NMIBC-PPSS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059686

Enrollment

105

Registered

2025-11-07

Start date

2027-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-risk non-muscle-invasive bladder cancer (HR-NMIBC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients must meet all of the following inclusion criteria to be included in the study: 1. Patients who reside in Japan and speak/read Japanese 2. Patients aged more than 18 years 3. Patients with self-reported HR-NMIBC 4. Patients who are willing and able to provide informed consent 5. Interview only: Patients who are able to participate in a video interview 6. Patient survey only: Patients who are able to access and complete an online survey

Exclusion criteria

Exclusion criteria: Patients meeting any of the following criteria will not be included in the study: 1. Patient survey only: Patients who participated in the interview survey

Design outcomes

Primary

Measure	Time frame
(1) Identification of the most valued treatment attributes by HR-NMIBC patients, (2) Insights into demographic and clinical factors influencing treatment preferences.	—

Countries

Japan

Contacts

Public ContactMiyu Okamura

Syneos Health Japan K.K. Real World Research

miyu.okamura@syneoshealth.com03-6733-9690

Outcome results